According to Stock Talk (@stocktalkweekly), Senators Bernie Sanders and Angus King are introducing a bill that would ban pharmaceutical manufacturers from direct-to-consumer advertising, as reported by the Wall Street Journal. This legislative move could significantly impact pharmaceutical stock valuations, particularly companies with large advertising budgets like Pfizer and Johnson & Johnson. For traders, the proposed ban may trigger volatility in pharma equities and potentially influence healthcare-related crypto tokens, as regulatory shifts in traditional markets often drive increased interest in decentralized health and DeFi projects. Source: Stock Talk, Wall Street Journal, June 12, 2025.